Yüklüyor......

Proteomic profiling of FBXW7‐mutant serous endometrial cancer cells reveals upregulation of PADI2, a potential therapeutic target

BACKGROUND: Despite advancements over the past decade revealing molecular aberrations characteristic of endometrial cancer (EC) subtypes, serous ECs remain difficult to treat and associated with poor outcomes. This is due, in part, to the rarity of these tumors within clinical trials and the inabili...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Med
Asıl Yazarlar: Urick, Mary Ellen, Bell, Daphne W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7286459/
https://ncbi.nlm.nih.gov/pubmed/32248654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3013
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!